APA (7th ed.) Citation

I, A., N, K., P, M., R, B., R, K., S, S., . . . H, S. (2023). PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia. Leukemia, 37(12), 2367. https://doi.org/10.1038/s41375-023-02041-5

Chicago Style (17th ed.) Citation

I, Alshamleh, et al. "PDP1 Is a Key Metabolic Gatekeeper and Modulator of Drug Resistance in FLT3-ITD-positive Acute Myeloid Leukemia." Leukemia 37, no. 12 (2023): 2367. https://doi.org/10.1038/s41375-023-02041-5.

MLA (9th ed.) Citation

I, Alshamleh, et al. "PDP1 Is a Key Metabolic Gatekeeper and Modulator of Drug Resistance in FLT3-ITD-positive Acute Myeloid Leukemia." Leukemia, vol. 37, no. 12, 2023, p. 2367, https://doi.org/10.1038/s41375-023-02041-5.